69
69
May 28, 2021
05/21
by
CNBC
tv
eye 69
favorite 0
quote 0
>> i think we have one of the interesting things is glaxo is in our international portfolio.t in because the area of revenue is the vaccine people were not getting other vaccines or going to the doctor. that has been ignored. it is also always traded at a discount to the u.s. counterparts take glaxo 5.8% yield look at johnson & johnson. 20 times earnings and 2.5% yield. diff i did this a long time ago revenues from both companies in north america and outside of north america. they are relatively equal in where they bring in their dollars. you have the huge multiple in this block it is not headquartered in the u.s. that is a great opportunity. particularly now with a little bit of love and appreciation is coming back into the international markets. >> domestically with medtronic mdt. >> right that is ois another one that is below the radar in the u.s one thing we heard is when people ask where the market will go between now and year end. a lot of talk is pull back or correction blah, blah, blah we are always looking at a correction we don't know if it is a month away or six mo
>> i think we have one of the interesting things is glaxo is in our international portfolio.t in because the area of revenue is the vaccine people were not getting other vaccines or going to the doctor. that has been ignored. it is also always traded at a discount to the u.s. counterparts take glaxo 5.8% yield look at johnson & johnson. 20 times earnings and 2.5% yield. diff i did this a long time ago revenues from both companies in north america and outside of north america. they are...
39
39
May 17, 2021
05/21
by
BLOOMBERG
tv
eye 39
favorite 0
quote 0
let's dig into the glaxo story. bloomberg health care reported joints me now.w about the delayed vaccine? susie: this is good news. both sonofi and glaxosmithkline will be breathing a sigh of relief. they have not been anywhere on the vaccine race. we had this delay in december. the way they had measured the concentration of the formulation had an error. they had not produced a strong enough response in order adults. we finally got the results today, which are positive. a similar response to people who have recovered from coronavirus, which is good news. now pushing ahead to the phase three trials which will start globally with about 37,000 people. new challenges with the vaccine rollout being incredibly strong. they will have to look elsewhere to make sure they can get data quick enough with the hopes they can still get authorized this year. alix: subject good point. secretary of state for health and social care in the u.k. matt hancock is speaking. he says there is over 2300 cases of the variant from india in the u.k.. he says the variant is not penetrating i
let's dig into the glaxo story. bloomberg health care reported joints me now.w about the delayed vaccine? susie: this is good news. both sonofi and glaxosmithkline will be breathing a sigh of relief. they have not been anywhere on the vaccine race. we had this delay in december. the way they had measured the concentration of the formulation had an error. they had not produced a strong enough response in order adults. we finally got the results today, which are positive. a similar response to...
24
24
tv
eye 24
favorite 0
quote 0
spreading quickly a new vaccine developed by french pharmaceuticals company santa fee and britain's glaxo smith kline has shown positive results in early stage clinical trials and germany's health minister says the country will soon stop prioritizing back to nations for more vulnerable groups beginning june 7th all adults in the country will be eligible. today is being called freedom monday by many people in england with much of the country easing its coronavirus lockdown rules most people can now eat and drink indoors visit friends and relatives outside their homes and go to the movies go to the gym for the 1st time in months but there are new concerns tonight about the spread of a highly contagious variant that was 1st detected in india. it's considered almost holy ground many in the u.k. see going to the pub with the same sanctity as visiting a church now residents of england whiles in scotland can do both britain relaxed a range of coronavirus restrictions on monday among the regained freedoms the ability to go to cinemas museums theaters and galleries again something that delighted n
spreading quickly a new vaccine developed by french pharmaceuticals company santa fee and britain's glaxo smith kline has shown positive results in early stage clinical trials and germany's health minister says the country will soon stop prioritizing back to nations for more vulnerable groups beginning june 7th all adults in the country will be eligible. today is being called freedom monday by many people in england with much of the country easing its coronavirus lockdown rules most people can...
52
52
tv
eye 52
favorite 0
quote 0
spreading fast and a new vaccine developed by the french pharmaceuticals company sun ofi and britain's glaxo smith kline has shown positive results in early stage clinical trials they'll now move to late stage trials in the coming weeks and germany's health minister says the country will soon stop prioritizing vaccinations for more vulnerable groups yes spawn said starting june 7th all adults will be eligible for jobs. and parts of the u.k. are easing long down rules today despite concerns over the spread of a coronavirus variant 1st detected in india pops restaurants are open for indoor drinking and dining after being closed for months and people are also a lot to get together with others at home for the 1st time since last fall and british holiday makers they're arriving in portugal one of the few countries the u.k. has designated as safe. sports news now for you the german football federation is officially looking for a new president after fitz keller handed in his resignation on monday he spent less than 2 years in the top job and leaves the role after comparing a colleague to an infamou
spreading fast and a new vaccine developed by the french pharmaceuticals company sun ofi and britain's glaxo smith kline has shown positive results in early stage clinical trials they'll now move to late stage trials in the coming weeks and germany's health minister says the country will soon stop prioritizing vaccinations for more vulnerable groups yes spawn said starting june 7th all adults will be eligible for jobs. and parts of the u.k. are easing long down rules today despite concerns over...
98
98
May 17, 2021
05/21
by
FBC
tv
eye 98
favorite 0
quote 0
we have glaxo smith klein, they say their experimental covid vaccine showing strong results.y it's efficacy is 95 to 100%. they plan to begin a new treys 3 trial in three weeks. both stocks up. micro strategy on the downside, i think, yes, it is. 5.8%, i guess this is because they hold a lot of bitcoin, susan? susan: they hold a lot of bitcoin. price of bitcoin which hit lowest level in more than 3 months. the business analytics companies hold roughly $5 billion bother and we hold that much and bitcoin prices go down and you go down along with it. square and jack dorsey, continuing to hold $170 million and they say that they will continue to buy despite the fact that they lost around $20 million so far on some of the bitcoin purchases. stuart: yeah, i mean, you see where i'm coming from, susan? you get the theatrics from elon musk and mark cuban affecting not just cryptos but the overall market. major league stocks here. susan: yeah. stuart: don't we have a lot of crypto-related stocks that are down this morning? susan: i want to throw minors as well. like the marathon pyton
we have glaxo smith klein, they say their experimental covid vaccine showing strong results.y it's efficacy is 95 to 100%. they plan to begin a new treys 3 trial in three weeks. both stocks up. micro strategy on the downside, i think, yes, it is. 5.8%, i guess this is because they hold a lot of bitcoin, susan? susan: they hold a lot of bitcoin. price of bitcoin which hit lowest level in more than 3 months. the business analytics companies hold roughly $5 billion bother and we hold that much and...